Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Products > 51-06-9

Detail of "51-06-9"

  • CAS Number:
  • 51-06-9
  • Name:
  • Benzamide,4-amino-N-[2-(diethylamino)ethyl]-

  • Superlist Name:
  • Procainamide
  • Molecular Structure:
  • Formula:
  • C13H21 N3 O
  • Molecular Weight:
  • 235.37
  • Synonyms:
  • Benzamide,p-amino-N-[2-(diethylamino)ethyl]- (8CI);4-Amino-N-(diethylaminoethyl)benzamide; 4-Amino-N-[2-(diethylamino)ethyl]benzamide;N-(2-(Diethylamino)ethyl)-4-aminobenzamide; NSC 27461; Novocainamid;Novocainamide; Novocaine amide; Novocamid; Procainamide; Procaine amide;Procanbid; SP 100; SP 100 (pharmaceutical);p-Amino-N-(2-diethylaminoethyl)benzamide; p-Aminobenzoic diethylaminoethylamide
  • EINECS:
  • 200-078-8
  • Density:
  • 1.060
  • Boiling Point:
  • 421.8°Cat760mmHg
  • Flash Point:
  • 208.9°C
  • Safety:
  • Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion. Human systemic effects by ingestion: cardiac abnormalities, joint effects, cough, tremors, dyspnea, and other lung effects. When heated to decomposition it emits toxic fumes of NOx. Details

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP
Please post your buying leads>>
Display:
  • Manufacturer
  • Enterprise Authentication
  • Suppiers of more reward points first
  • New supplier

CAS No.51-06-9 Procainamide

Supplier:SHIJIAZHAUNG KUNLI CHEMICAL CO.LTD., [ China (Mainland)]

Platinum
Supplier
1570Integral
1570

Tel:0311-85233798

Address:shijiazhuang

Contact Suppliers

CAS No.51-06-9 Procainamide

Supplier:Absolute Standards, Inc. [ United States]

122Integral
122

Tel:+1 (800) 368-1131

Address:P O Box 5585 Hamden, CT 06518 USA

Contact Suppliers

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Reference

The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers
The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers. Arnsdorf, Morton F.; Sawicki, George J. (Pritzker Sch. Med., Univ. Chicago, Chicago, Ill., USA). J. Pharmacol. Exp. Ther., 201(3), 689-700 (English) 1977. CODEN: JPETAB. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) Triggered sustained rhythmic activity (TSRA) was seen in eight sheep Purkinje fibers during the course of microelectrode studies. This TSRA had the following characteristics: (1) it was obsd. in Purkinje fibers having otherwise essentially normal membrane properties; (2) it occurred when the Purkinje fibers were bathed in physiologic Tyrode's solution at [K]0 = 4 mM; (3) a single electrically induced action potential initiated either sustained nondriven action potentials or oscillations that increased in amplitude eventuating in sustained nondriven action potentials; and (4) either it terminated spontaneously by reaching repolarization threshold with a return to the resting transmembrane voltage (Vr) or persisted essentially indefinitely until terminated by intracellularly applied hyperpolarizing current. Procaine amide [51-06-9], lidocaine (I) [137-58-6] and a .beta.-receptor blocker tolamolol [38103-61-6] were effective against TSRA. Current-voltage relationships were performed using two microelectrodes: one for intracellular current application; the other for transmembrane voltage recording. Procaine amide decreased the amplitude of nondriven sustained action potentials and, in time, often resulted in one or two steady quiescent states: at about -30 mV and/or Vr. I did not decrease the nondriven sustained action potential amplitude, but made its maximal diastolic transmembrane voltage more negative thereby permitting attainment of the repolarization threshold and a return to Vr: am action suggested by the current-voltage relationships to be mediated by increasing membrane potassium conductance. The effects of procaine amide and I were different and additive. Tolamolol immediately suppressed TSRA.
Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography
Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography. Dutcher, John S.; Strong, John M. (Clin. Pharmacol. Cent., Northwest. Univ. Med. Sch., Chicago, Ill., USA). Clin. Chem. (Winston-Salem, N. C.), 23(7), 1318-20 (English) 1977. CODEN: CLCHAU. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) A routine method for detg. concns. of the antiarrhythmic drug procainamide (I) [51-06-9] and its active metabolite, N-acetylprocainamide [32795-44-1], in plasma is described. A simple extraction of 1.0 mL of plasma is followed by sepn. and chromatog. anal. by use of a column contg. microparticulate silica. P-Nitro-N-(2-diethylaminoethyl)benzamide hydrochloride was synthesized and used as the internal standard. Total chromatog. time is only 7 min. The day-to-day coeffs. of variation during three months of daily use were less than 4% of the mean for each compd., and no deterioration in column performance during this time was obsd. Phenobarbital, phenytoin, lidocaine, primidone, methsuximide, quinidine, and their metabolites do not interfere.
Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620